MedTrace Logo

Papillary Thyroid Cancer and Central Lymp Node Dissection

NCT05873283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-05-24

No results posted yet for this study

Summary

Papillary cancer is a disease that spreads through lymphatic ways and its treatment is surgery. We performed prophylactic central dissection in addition to bilateral total thyroidectomy in patients with bethesda 5 and bethesda 6 biopsy results. We evaluated the pathology results retrospectively.

Conditions

  • Papillary Thyroid Cancer

Sponsors & Collaborators

  • Başakşehir Çam & Sakura City Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2022-02-01
Completion
2023-03-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05873283 on ClinicalTrials.gov